PortfoliosLab logoPortfoliosLab logo
POWL vs. SMMT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

POWL vs. SMMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Powell Industries, Inc. (POWL) and Summit Therapeutics Inc. (SMMT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, POWL achieves a 177.61% return, which is significantly higher than SMMT's -19.90% return. Over the past 10 years, POWL has outperformed SMMT with an annualized return of 40.56%, while SMMT has yielded a comparatively lower 5.31% annualized return.


POWL

1D
1.46%
1M
-1.99%
YTD
177.61%
6M
162.55%
1Y
358.62%
3Y*
146.47%
5Y*
94.19%
10Y*
40.56%

SMMT

1D
7.11%
1M
-25.44%
YTD
-19.90%
6M
-20.26%
1Y
-30.51%
3Y*
93.96%
5Y*
15.49%
10Y*
5.31%
*Multi-year figures are annualized to reflect compound growth (CAGR)

POWL vs. SMMT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
POWL
Powell Industries, Inc.
177.61%44.49%152.21%155.62%24.34%3.60%-37.60%101.58%-9.92%-24.00%
SMMT
Summit Therapeutics Inc.
-19.90%-1.99%583.72%-38.59%57.99%-42.77%193.75%39.13%-89.62%29.44%

Correlation

The correlation between POWL and SMMT is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Mar 5, 2015

0.12

Fundamentals

Market Cap

POWL:

$10.77B

SMMT:

$10.86B

EPS

POWL:

$5.12

SMMT:

-$1.60

PB Ratio

POWL:

15.19

SMMT:

19.90

Total Revenue (TTM)

POWL:

$1.13B

SMMT:

$0.00

Gross Profit (TTM)

POWL:

$340.78M

SMMT:

-$83.36K

EBITDA (TTM)

POWL:

$236.11M

SMMT:

-$738.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

POWL vs. SMMT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

POWL
POWL Risk / Return Rank: 9898
Overall Rank
POWL Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
POWL Sortino Ratio Rank: 9898
Sortino Ratio Rank
POWL Omega Ratio Rank: 9696
Omega Ratio Rank
POWL Calmar Ratio Rank: 9898
Calmar Ratio Rank
POWL Martin Ratio Rank: 9999
Martin Ratio Rank

SMMT
SMMT Risk / Return Rank: 2626
Overall Rank
SMMT Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
SMMT Sortino Ratio Rank: 2929
Sortino Ratio Rank
SMMT Omega Ratio Rank: 2929
Omega Ratio Rank
SMMT Calmar Ratio Rank: 2323
Calmar Ratio Rank
SMMT Martin Ratio Rank: 2626
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

POWL vs. SMMT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Powell Industries, Inc. (POWL) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


POWLSMMTDifference
Sharpe ratioReturn per unit of total volatility

+6.44

Sortino ratioReturn per unit of downside risk

+4.98

Omega ratioGain probability vs. loss probability

1.60

0.98

+0.62

Calmar ratioReturn relative to maximum drawdown

11.71

-0.55

+12.26

Martin ratioReturn relative to average drawdown

36.97

-0.87

+37.84

POWL vs. SMMT - Sharpe Ratio Comparison

The current POWL Sharpe Ratio is 6.03, which is higher than the SMMT Sharpe Ratio of -0.41. The chart below compares the historical Sharpe Ratios of POWL and SMMT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

POWL vs. SMMT - Drawdown Comparison

The maximum POWL drawdown since its inception was -73.10%, smaller than the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for POWL and SMMT.


Loading charts...

Drawdown Indicators


POWLSMMTDifference

Max Drawdown

Largest peak-to-trough decline

-73.10%

-95.75%

+22.65%

Max Drawdown (1Y)

Largest decline over 1 year

-30.88%

-55.49%

+24.61%

Max Drawdown (3Y)

Largest decline over 3 years

-55.76%

-64.44%

+8.68%

Max Drawdown (5Y)

Largest decline over 5 years

-55.76%

-91.78%

+36.02%

Max Drawdown (10Y)

Largest decline over 10 years

-68.85%

-95.75%

+26.90%

Current Drawdown

Current decline from peak

-8.45%

-61.83%

+53.38%

Average Drawdown

Average peak-to-trough decline

-36.09%

-57.63%

+21.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.76%

34.94%

-25.18%

Volatility

POWL vs. SMMT - Volatility Comparison

The current volatility for Powell Industries, Inc. (POWL) is 19.86%, while Summit Therapeutics Inc. (SMMT) has a volatility of 23.99%. This indicates that POWL experiences smaller price fluctuations and is considered to be less risky than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


POWLSMMTDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.86%

23.99%

-4.13%

Volatility (6M)

Calculated over the trailing 6-month period

44.83%

56.65%

-11.82%

Volatility (1Y)

Calculated over the trailing 1-year period

59.91%

75.61%

-15.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

64.36%

185.08%

-120.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

54.84%

144.46%

-89.62%

Dividends

POWL vs. SMMT - Dividend Comparison

POWL's dividend yield for the trailing twelve months is around 0.12%, while SMMT has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
POWL
Powell Industries, Inc.
0.12%0.34%0.48%1.19%2.96%3.53%3.53%2.12%4.16%3.63%2.67%4.00%
SMMT
Summit Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

POWL vs. SMMT - Financials Comparison

This section allows you to compare key financial metrics between Powell Industries, Inc. and Summit Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-50.00M0.0050.00M100.00M150.00M200.00M250.00M300.00M20222023202420252026
296.62M
0
(POWL) Total Revenue
(SMMT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


POWL and SMMT have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SMMT has higher volatility (23.99%) compared to POWL (19.86%). In terms of maximum drawdown, POWL dropped -73.10% vs SMMT's -95.75%.

POWL currently has the higher Sharpe Ratio (6.03 vs -0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for POWL and SMMT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer